caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1063409241

Steven Olszewski

Radiation OncologyMiami, FLI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
REFERRAL NETWORK

Where Steven Olszewski's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 6 inbound referrers · 10 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Federico Albrecht
Hematology-Oncology · Miami, FL
25365
Antonio Muina
Hematology-Oncology · Miami, FL
24301
Peter Citron
Hematology-Oncology · Miami, FL
20318
Hao Vuong
Diagnostic Radiology · Miami, FL
1569
ROSZLER, MYER1146
TRONER, MICHAEL1196
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
SOUTH MIAMI HOSPITAL INC891,024
Maria-Amelia Rodrigues
Radiation Oncology · Miami, FL
614,449
Quest Diagnostics Clinical Laboratories Inc
Clinical Laboratory · Miramar, FL
54553
Peter Citron
Hematology-Oncology · Miami, FL
23272
Federico Albrecht
Hematology-Oncology · Miami, FL
23399
Antonio Muina
Hematology-Oncology · Miami, FL
19314
Frances Behrmann
Hematology-Oncology · Miami, FL
19221
Siddhartha Venkatappa
Hematology-Oncology · Miami, FL
17124
BAPTIST HOSPITAL OF MIAMI INC1375
Grace Wang
Hematology-Oncology · Miami, FL
1148
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
11
Beneficiaries
—
Total drug cost
$92
Distinct drugs
1
Brand share
0.0%
Top prescribed drugs
Prednisone11 claims
QUALITY · MIPS · 2024
Final MIPS score
92.6
Quality
72.2
Cost
77.6
Improvement activities
40.0
Promoting interop.
99.0
Payment adjustment
0.74%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
No data available for this provider in 2024.